Clinical trial
ESGVS: Sclerotherapy With Lauromacrogol
NCT00348764 · University Hospital, Grenoble, Other · Completed
Key facts
| NCT number | NCT00348764 |
|---|---|
| Title | ESGVS: Sclerotherapy With Lauromacrogol |
| Official title | Treatment of Greater Saphenous Vein (GSV) Insufficiency Using Echo-Guided Sclerotherapy With Lauromacrogol 400 Foam -Comparative Study of 3% Versus 1% Concentration. |
| Lead sponsor | University Hospital, Grenoble, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Venous Insufficiency, Saphenous Vein |
| Intervention type | Drug |
| Interventions | lauromacrogol |
| Enrollment | 150 |
| Start date | Mar 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Jul 6, 2006 |
| Last update posted | Jul 6, 2006 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: